Reasons for the sharp decline in the number of patents for Wuxi PharmaTech's second equity incentive

The upcoming incentive trust plan will seriously erode the profits of listed companies and shareholders' rights and interests. The reason why the number of Wuxi PharmaTech's second equity incentive patents dropped sharply was that the upcoming incentive trust plan seriously eroded the profits of listed companies and shareholders' rights and interests. As long as shareholder Qi Xin votes against it, the bill will not be passed, and his own interests must be protected by himself. Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi. Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi, Wuxi.